Episode 254 - Erick Lucera (CFO) & Vikram Ranade (CBO) at Dyne Therapeutics
From The BioHub - by Avetix · · 29 min
This plays from the publisher's own server. We do not host a copy.
Not rated yet
Description
Today, we’re joined by Erick Lucera, Chief Financial Officer, and Vikram Ranade, Chief Business Officer at Dyne Therapeutics. We’ll be discussing their individual journeys through biotech, what attracted them to Dyne, and the company’s mission to develop transformative treatments for people living with genetically driven neuromuscular diseases. We’ll also explore the strategy behind building a biotech towards commercialisation, the financial and business development challenges involved, and their perspectives on the wider biotech landscape.